IGI
This article was originally published in The Rose Sheet
Executive Summary
President Paul Woitach to CEO Feb. 1, succeeding Edward Hagar, MD. Woitach, along with Exec VP Robert McDaniel and CFO Manfred Hanuschek, will be responsible for daily management and operations. Hagar will remain chairman of both the board and executive committee. IGI markets the patented Novasome encapsulation technology, which aids in the delivery of cosmetics and skin care products to the skin